Caas Capital Management LP Rani Therapeutics Holdings, Inc. Transaction History

Caas Capital Management LP

  • $836 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$12.21 - $23.14 $170,134 - $322,432
-13,934 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$16.09 - $35.0 $982,551 - $2.14 Million
-61,066 Reduced 81.42%
13,934 $228,000
Q3 2021

Nov 15, 2021
BUY
$10.7 - $21.43 $802,500 - $1.61 Million
75,000 New
75,000 $1.34 Million

Others Institutions Holding RANI

# of Institutions
35
Shares Held
5.77M
Call Options Held
2.5K
Put Options Held
2.2K
View Full List

About Rani Therapeutics Holdings, Inc.

RANI Quotes by TradingView
  • Ticker RANI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,492,000
  • Market Cap $35.8M
  • Description
  • Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...
More about RANI
Track This Portfolio

Track Caas Capital Management LP Portfolio

Follow Caas Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Caas Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email